Heska Corp. (NASDAQ:HSKA) hit a new 52-week high during trading on Tuesday . The stock traded as high as $52.33 and last traded at $52.10, with a volume of 69,196 shares. The stock had previously closed at $50.35.

HSKA has been the subject of several analyst reports. Sidoti initiated coverage on shares of Heska Corp. in a research report on Friday, July 1st. They set a “buy” rating and a $49.00 price target for the company. Zacks Investment Research upgraded shares of Heska Corp. from a “hold” rating to a “buy” rating and set a $48.00 price target for the company in a research report on Wednesday, July 13th. TheStreet upgraded shares of Heska Corp. from a “hold” rating to a “buy” rating in a research report on Wednesday, May 25th. Gabelli cut shares of Heska Corp. from a “buy” rating to a “hold” rating in a research report on Thursday, August 4th. Finally, B. Riley reiterated a “buy” rating and set a $42.50 price target on shares of Heska Corp. in a research report on Monday, May 9th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $52.83.

The stock has a market capitalization of $346.87 million and a PE ratio of 52.49. The stock’s 50-day moving average price is $42.38 and its 200 day moving average price is $35.34.

Heska Corp. (NASDAQ:HSKA) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported $0.35 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.18 by $0.17. The firm had revenue of $30 million for the quarter, compared to the consensus estimate of $28.47 million. The firm’s revenue for the quarter was up 25.5% compared to the same quarter last year. On average, equities analysts forecast that Heska Corp. will post $1.03 EPS for the current year.

In other news, CEO Kevin S. Wilson sold 14,040 shares of the stock in a transaction dated Friday, July 1st. The shares were sold at an average price of $38.94, for a total value of $546,717.60. Following the completion of the transaction, the chief executive officer now owns 165,960 shares of the company’s stock, valued at $6,462,482.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Kevin S. Wilson sold 30,736 shares of the stock in a transaction dated Wednesday, August 3rd. The stock was sold at an average price of $47.34, for a total transaction of $1,455,042.24. Following the completion of the transaction, the chief executive officer now directly owns 140,720 shares of the company’s stock, valued at approximately $6,661,684.80. The disclosure for this sale can be found here.

An institutional investor recently bought a new position in Heska Corp. stock. Ancora Advisors LLC bought a new position in Heska Corp. (NASDAQ:HSKA) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 101,100 shares of the company’s stock, valued at approximately $1,833,000. Ancora Advisors LLC owned approximately 1.53% of Heska Corp. at the end of the most recent reporting period.

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.